Insider Trading Summary for Seres Therapeutics, Inc. (MCRB): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-May-24 8:14 PM View:	15-May-24 Planned Option Sale ($0.79K)	Desrosier Thomas Chief Legal Officer and EVP		Seres Therapeutics, Inc. - MCRB	7% 113.89K to 122.39K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:15 PM View:	18-Nov-24 Planned Option Sale ($0.50K)	Henn Matthew R. See Remarks		Seres Therapeutics, Inc. - MCRB	38% 56.36K to 77.77K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:20 PM View:	18-Nov-24 Planned Option Sale ($0.53K)	von Moltke Lisa See Remarks		Seres Therapeutics, Inc. - MCRB	241% 9.51K to 32.41K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:15 PM View:	18-Nov-24 Planned Option Sale ($0.40K)	Young Teresa L. See Remarks		Seres Therapeutics, Inc. - MCRB	969% 8.45K to 90.4K	0	0	--	--	Show Txns Hide Txns

19-Aug-24 5:29 PM View:	16-Aug-24 Planned Option Sale ($0.95K)	Ege David S. See Remarks		Seres Therapeutics, Inc. - MCRB	16% 66.99K to 77.58K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:15 PM View:	18-Nov-24 Planned Option Sale ($1.35K)	Shaff Eric D. CEO and President Director		Seres Therapeutics, Inc. - MCRB	47% 115.62K to 170.39K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 9:13 PM View:	16-Feb-24 Planned Option Sale ($4.25K)	Arkowitz David Chief Financial Officer		Seres Therapeutics, Inc. - MCRB	4% 175.76K to 182.44K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--